Mackenzie Financial’s Phibro Animal Health PAHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-75,044
Closed -$4.15M 1656
2026
Q1
$4.15M Buy
75,044
+24,425
+48% +$1.16M 0.01% 721
2025
Q4
$1.89M Buy
50,619
+3,355
+7% +$136K ﹤0.01% 893
2025
Q3
$1.91M Buy
47,264
+10,411
+28% +$344K ﹤0.01% 846
2025
Q2
$941K Buy
36,853
+26,748
+265% +$583K ﹤0.01% 1024
2025
Q1
$216K Sell
10,105
-12,644
-56% -$283K ﹤0.01% 1487
2024
Q4
$478K Buy
+22,749
New +$526K ﹤0.01% 1191

Other funds holding PAHC

Mackenzie Financial's PAHC Position: Q2 2026 in Review

Mackenzie Financial sold out of Phibro Animal Health (PAHC) in Q2 2026, closing a stake of 75,044 shares — an estimated $4.15M sold.

Mackenzie Financial first reported a position in PAHC in Q4 2024 and held it in 6 quarters. The position peaked at $4.15M in Q1 2026. 208 funds tracked by Wall St. Rank hold PAHC as of Q2 2026.

  • Mackenzie Financial reported no remaining Phibro Animal Health position as of Q2 2026 after selling out during the quarter.
  • Mackenzie Financial sold 75,044 Phibro Animal Health shares in Q2 2026, an estimated $4.15M.
  • Mackenzie Financial first reported a position in Phibro Animal Health in Q4 2024 and held it in 6 quarters.
  • Mackenzie Financial's Phibro Animal Health position peaked at $4.15M in Q1 2026.
  • 208 funds tracked by Wall St. Rank held Phibro Animal Health as of Q2 2026.

Based on Mackenzie Financial's 13F filing for Q2 2026, filed 13 Aug 2026.